References:
1. Camont, L; Cottart, C; Rhayem, Y; Nivetantoine, V; Djelidi, R; Collin, F; Beaudeux, J; Bonnefontrousselot, D (2009). "Simple spectrophotometric assessment of the trans-/cis-resveratrol ratio in aqueous solutions". Analytica Chimica Acta 634 (1): 121"8. doi:10.1016/j.aca.2008.12.003. PMID 19154820.
2. Resveratrol MSDS on Fisher Scientific website
3. Resveratrol MSDS on http://www.sigmaaldrich.com
4. Bechmann, LP; Zahn, D; Gieseler, RK; Fingas, CD; Marquitan, G; Jochum, C; Gerken, G; Friedman, SL et al. (2009). "Resveratrol amplifies profibrogenic effects of free fatty acids on human hepatic stellate cells". Hepatology research : the official journal of the Japan Society of Hepatology 39 (6): 601"8. doi:10.1111/j.1872-034X.2008.00485.x. PMC 2893585. PMID 19207580.
5. Bass TM, Weinkove D, Houthoofd K, Gems D, Partridge L (October 2007). "Effects of resveratrol on lifespan in Drosophila melanogaster and Caenorhabditis elegans". Mech. Ageing Dev. 128 (10): 546"52. doi:10.1016/j.mad.2007.07.007. PMID 17875315.
6. "Micronutrient Information Center: Resveratrol". Linus Pauling Institute at Oregon State University. Retrieved 2012-01-13.
7. Elliott PJ, Jirousek M (April 2008). "Sirtuins: novel targets for metabolic disease". Curr Opin Investig Drugs 9 (4): 371"8. PMID 18393104.
8. "Sirtris Announces Positive Results with Proprietary Version of Resveratrol, SRT501, in a Phase 1b Type 2 Diabetes Clinical Study - Drugs.com MedNews". Press Release. Drugs.com. 2008-01-07. Retrieved 2012-02-22.
9. "Pharma seeks genetic clues to healthy aging". Reuters. 6 April 2010.
10. The Connecticut Post, "Selling resveratrol: Wonder drug or snake oil?," 08/04/2009, by Melissa Healy for the Los Angeles Times news service
11. Gehm BD, McAndrews JM, Chien PY, Jameson JL (December 1997). "Resveratrol, a polyphenolic compound found in grapes and wine, is an agonist for the estrogen receptor". Proc. Natl. Acad. Sci. U.S.A. 94 (25): 14138"43. doi:10.1073/pnas.94.25.14138. PMC 28446. PMID 9391166.
12. Baur JA, Sinclair DA (June 2006). "Therapeutic potential of resveratrol: the in vivo evidence". Nat Rev Drug Discov 5 (6): 493"506. doi:10.1038/nrd2060. PMID 16732220.
13. Farina A, Ferranti C, Marra C (March 2006). "An improved synthesis of resveratrol". Nat. Prod. Res. 20 (3): 247"52. doi:10.1080/14786410500059532. PMID 16401555.
14. Trantas E, Panopoulos N, Ververidis F (November 2009). "Metabolic engineering of the complete pathway leading to heterologous biosynthesis of various flavonoids and stilbenoids in Saccharomyces cerevisiae". Metab. Eng. 11 (6): 355"66. doi:10.1016/j.ymben.2009.07.004. PMID 19631278.
15. Wang, H.; Liu, L.; Guo, Y.-X.; Dong, Y.-S.; Zhang, D.-J.; Xiu, Z.-L. (2007). "Biotransformation of piceid in Polygonum cuspidatum to resveratrol by Aspergillus oryzae". Applied Microbiology and Biotechnology 75 (4): 763"8. doi:10.1007/s00253-007-0874-3. PMID 17333175.
16. Stilbene derivatives from Gnetum cleistostachyum. Chun-Suo Yao, Mao Lin, Xin Liu and Ying-Hong Wang, Journal of Asian Natural Products Research, 2005, Volume 7, Issue 2, pages 131-137, doi:10.1080/10286020310001625102, PubMed
17. Resveratrol, a new phenolic compound, from Veratrum grandiflorum. M Takaoka, Journal of the Chemical Society of Japan, 1939, volume 60, pages 1090-1100 (abstract)
18. Schrder, Joachim (March 6, 2010). "Discovery of resveratrol". Resveratrol.[self-published source?]
19. Howitz KT, Bitterman KJ, Cohen HY, Lamming DW, Lavu S, Wood JG, Zipkin RE, Chung P, Kisielewski A, Zhang LL, Scherer B, Sinclair DA (September 2003). "Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan". Nature 425 (6954): 191"6. doi:10.1038/nature01960. PMID 12939617.
20. Wood JG, Rogina B, Lavu S, Howitz K, Helfand SL, Tatar M, Sinclair D (August 2004). "Sirtuin activators mimic caloric restriction and delay ageing in metazoans". Nature 430 (7000): 686"9. doi:10.1038/nature02789. PMID 15254550.
21. Gruber J, Tang SY, Halliwell B (April 2007). "Evidence for a trade-off between survival and fitness caused by resveratrol treatment of Caenorhabditis elegans". Ann. N. Y. Acad. Sci. 1100: 530"42. doi:10.1196/annals.1395.059. PMID 17460219.
22. Valenzano DR, Terzibasi E, Genade T, Cattaneo A, Domenici L, Cellerino A (February 2006). "Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate". Curr. Biol. 16 (3): 296"300. doi:10.1016/j.cub.2005.12.038. PMID 16461283.
23. Baur JA, Pearson KJ, Price NL, Jamieson HA, Lerin C, Kalra A, Prabhu VV, Allard JS, Lopez-Lluch G, Lewis K, Pistell PJ, Poosala S, Becker KG, Boss O, Gwinn D, Wang M, Ramaswamy S, Fishbein KW, Spencer RG, Lakatta EG, Le Couteur D, Shaw RJ, Navas P, Puigserver P, Ingram DK, de Cabo R, Sinclair DA (November 2006). "Resveratrol improves health and survival of mice on a high-calorie diet". Nature 444 (7117): 337"42. doi:10.1038/nature05354. PMID 17086191.
24. Pearson KJ, Baur JA, Lewis KN, Peshkin L, Price NL, Labinskyy N, Swindell WR, Kamara D, Minor RK, Perez E, Jamieson HA, Zhang Y, Dunn SR, Sharma K, Pleshko N, Woollett LA, Csiszar A, Ikeno Y, Le Couteur D, Elliott PJ, Becker KG, Navas P, Ingram DK, Wolf NS, Ungvari Z, Sinclair DA, de Cabo R (August 2008). "Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span". Cell Metab. 8 (2): 157"68. doi:10.1016/j.cmet.2008.06.011. PMC 2538685. PMID 18599363.
25. Miller RA, Harrison DE, Astle CM, Floyd RA, Flurkey K, Hensley KL, Javors MA, Leeuwenburgh C, Nelson JF, Ongini E, Nadon NL, Warner HR, Strong R (August 2007). "An Aging Interventions Testing Program: study design and interim report". Aging Cell 6 (4): 565"75. doi:10.1111/j.1474-9726.2007.00311.x. PMID 17578509.
26. Miller RA, Harrison DE, Astle CM, Baur JA, Boyd AR, de Cabo R, Fernandez E, Flurkey K, Javors MA, Nelson JF, Orihuela CJ, Pletcher S, Sharp ZD, Sinclair D, Starnes JW, Wilkinson JE, Nadon NL, Strong R (February 2011). "Rapamycin, but not resveratrol or simvastatin, extends life span of genetically heterogeneous mice". J. Gerontol. A Biol. Sci. Med. Sci. 66 (2): 191"201. doi:10.1093/gerona/glq178. PMC 3021372. PMID 20974732.
27. Kaeberlein, Matt; McDonagh, Thomas; Heltweg, Birgit; Hixon, Jeffrey; Westman, Eric A.; Caldwell, Seth D.; Napper, Andrew; Curtis, Rory; DiStefano, Peter S.; Fields, Stanley; Bedalov, Antonio; Kennedy, Brian K. (April 2005). "Substrate-specific activation of sirtuins by resveratrol". Journal of Biological Chemistry 208 (17): 17038"17045. doi:10.1074/jbc.M500655200. PMID 15684413. Retrieved November 14, 2012.
28. Wade, Nicholas (November 16, 2006). "Red Wine Ingredient Increases Endurance, Study Shows". New York Times.
29. Lagouge M, Argmann C, Gerhart-Hines Z, Meziane H, Lerin C, Daussin F, Messadeq N, Milne J, Lambert P, Elliott P, Geny B, Laakso M, Puigserver P, Auwerx J (December 2006). "Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha". Cell 127 (6): 1109"22. doi:10.1016/j.cell.2006.11.013. PMID 17112576.
30. "'Longevity gene' may be dead end: study". The Raw Story. Agence France-Presse. September 12, 2011.
31. Ledford, Heidi (2011). "Longevity genes challenged". Nature. doi:10.1038/news.2011.549.
32. Viswanathan M, Guarente L (September 2011). "Regulation of Caenorhabditis elegans lifespan by sir-2.1 transgenes". Nature 477 (7365): E1"2. doi:10.1038/nature10440. PMID 21938026.
33.Lombard DB, Pletcher SD, Cant C, Auwerx J (September 2011). "Ageing: longevity hits a roadblock". Nature 477 (7365): 410"1. doi:10.1038/477410a. PMID 21938058.
34. Hubbard, Basil P.; Ana P. Gomes, Han Dai, Jun Li, April W. Case, Thomas Considine, Thomas V. Riera, Jessica E. Lee, Sook Yen E, Dudley W. Lamming, Bradley L. Pentelute, Eli R. Schuman, Linda A. Stevens, Alvin J. Y. Ling, Sean M. Armour, Shaday Michan, Huizhen Zhao, Yong Jiang, Sharon M. Sweitzer, Charles A. Blum, Jeremy S. Disch, Pui Yee Ng, Konrad T. Howitz, Anabela P. Rolo, Yoshitomo Hamuro, Joel Moss, Robert B. Perni, James L. Ellis, George P. Vlasuk, David A. Sinclair (2013). "Evidence for a Common Mechanism of SIRT1 Regulation by Allosteric Activators". Science. doi:10.1126/science.1231097.
35. Jang M, Cai L, Udeani GO, Slowing KV, Thomas CF, Beecher CW, Fong HH, Farnsworth NR, Kinghorn AD, Mehta RG, Moon RC, Pezzuto JM (January 1997). "Cancer chemopreventive activity of resveratrol, a natural product derived from grapes". Science 275 (5297): 218"20. doi:10.1126/science.275.5297.218. PMID 8985016.
36. Lin, KH; Hsiao, G; Shih, CM; Chou, DS; Sheu, JR (2009). "Mechanisms of resveratrol-induced platelet apoptosis". Cardiovascular research 83 (3): 575"85. doi:10.1093/cvr/cvp139. PMID 19423619.
37. Wang Z, Huang Y, Zou J, Cao K, Xu Y, Wu JM (January 2002). "Effects of red wine and wine polyphenol resveratrol on platelet aggregation in vivo and in vitro". Int. J. Mol. Med. 9 (1): 77"9. PMID 11745001. edit
38. Zou J, Huang Y, Chen Q, Wang N, Cao K, Hsieh TC, Wu JM (October 1999). "Suppression of mitogenesis and regulation of cell cycle traverse by resveratrol in cultured smooth muscle cells". Int. J. Oncol. 15 (4): 647"51. PMID 10493944. edit
39. Brito PM, Devillard R, Ngre-Salvayre A, Almeida LM, Dinis TC, Salvayre R, Aug N (July 2009). "Resveratrol inhibits the mTOR mitogenic signaling evoked by oxidized LDL in smooth muscle cells". Atherosclerosis 205 (1): 126"34. doi:10.1016/j.atherosclerosis.2008.11.011. PMID 19108833. edit
40. Athar M, Back JH, Tang X, Kim KH, Kopelovich L, Bickers DR, Kim AL (November 2007). "Resveratrol: a review of preclinical studies for human cancer prevention". Toxicol. Appl. Pharmacol. 224 (3): 274"83. doi:10.1016/j.taap.2006.12.025. PMC 2083123. PMID 17306316.
41. Resveratrol. From Clinicaltrials.gov. Retrieved August 15, 2008.
42. Boocock DJ, Faust GE, Patel KR, Schinas AM, Brown VA, Ducharme MP, Booth TD, Crowell JA, Perloff M, Gescher AJ, Steward WP, Brenner DE (June 2007). "Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent". Cancer Epidemiol. Biomarkers Prev. 16 (6): 1246"52. doi:10.1158/1055-9965.EPI-07-0022. PMID 17548692.
43. Niles RM, Cook CP, Meadows GG, Fu YM, McLaughlin JL, Rankin GO (October 2006). "Resveratrol is rapidly metabolized in athymic (nu/nu) mice and does not inhibit human melanoma xenograft tumor growth". J. Nutr. 136 (10): 2542"6. PMC 1612582. PMID 16988123.
44. Wenzel E, Soldo T, Erbersdobler H, Somoza V (May 2005). "Bioactivity and metabolism of trans-resveratrol orally administered to Wistar rats". Mol Nutr Food Res 49 (5): 482"94. doi:10.1002/mnfr.200500003. PMID 15779067.
45. Li ZG, Hong T, Shimada Y, Komoto I, Kawabe A, Ding Y, Kaganoi J, Hashimoto Y, Imamura M (September 2002). "Suppression of N-nitrosomethylbenzylamine (NMBA)-induced esophageal tumorigenesis in F344 rats by resveratrol". Carcinogenesis 23 (9): 1531"6. doi:10.1093/carcin/23.9.1531. PMID 12189197.
46. Gao X, Xu YX, Divine G, Janakiraman N, Chapman RA, Gautam SC (July 2002). "Disparate in vitro and in vivo antileukemic effects of resveratrol, a natural polyphenolic compound found in grapes". J. Nutr. 132 (7): 2076"81. PMID 12097696.
47. Kimura Y, Okuda H (June 2001). "Resveratrol isolated from Polygonum cuspidatum root prevents tumor growth and metastasis to lung and tumor-induced neovascularization in Lewis lung carcinoma-bearing mice". J. Nutr. 131 (6): 1844"9. PMID 11385077.
48. Barger JL, Kayo T, Vann JM, Arias EB, Wang J, Hacker TA, Wang Y, Raederstorff D, Morrow JD, Leeuwenburgh C, Allison DB, Saupe KW, Cartee GD, Weindruch R, Prolla TA (2008). "A low dose of dietary resveratrol partially mimics caloric restriction and retards aging parameters in mice". In Tom, Daniel. PLoS ONE 3 (6): e2264. doi:10.1371/journal.pone.0002264. PMC 2386967. PMID 18523577.
49. Szmitko PE, Verma S (January 2005). "Cardiology patient pages. Red wine and your heart". Circulation 111 (2): e10"1. doi:10.1161/01.CIR.0000151608.29217.62. PMID 15657377.
50. Ferrires J (January 2004). "The French paradox: lessons for other countries". Heart 90 (1): 107"11. doi:10.1136/heart.90.1.107. PMC 1768013. PMID 14676260.
51. Simini B (January 2000). "Serge Renaud: from French paradox to Cretan miracle". Lancet 355 (9197): 48. doi:10.1016/S0140-6736(05)71990-5. PMID 10615898.
52. Renaud S, de Lorgeril M (June 1992). "Wine, alcohol, platelets, and the French paradox for coronary heart disease". Lancet 339 (8808): 1523"6. doi:10.1016/0140-6736(92)91277-F. PMID 1351198.
53. Kopp P (June 1998). "Resveratrol, a phytoestrogen found in red wine. A possible explanation for the conundrum of the 'French paradox'?". Eur. J. Endocrinol. 138 (6): 619"20. doi:10.1530/eje.0.1380619. PMID 9678525.
54. Ferrero ME, Bertelli AE, Fulgenzi A, Pellegatta F, Corsi MM, Bonfrate M, Ferrara F, De Caterina R, Giovannini L, Bertelli A (December 1998). "Activity in vitro of resveratrol on granulocyte and monocyte adhesion to endothelium". Am. J. Clin. Nutr. 68 (6): 1208"14. PMID 9846848.
55. Rotondo S, Rajtar G, Manarini S, Celardo A, Rotillo D, de Gaetano G, Evangelista V, Cerletti C (April 1998). "Effect of trans-resveratrol, a natural polyphenolic compound, on human polymorphonuclear leukocyte function". Br. J. Pharmacol. 123 (8): 1691"9. doi:10.1038/sj.bjp.0701784. PMC 1565338. PMID 9605577.
56. Haider UG, Roos TU, Kontaridis MI, Neel BG, Sorescu D, Griendling KK, Vollmar AM, Dirsch VM (July 2005). "Resveratrol inhibits angiotensin II- and epidermal growth factor-mediated Akt activation: role of Gab1 and Shp2". Mol. Pharmacol. 68 (1): 41"8. doi:10.1124/mol.104.005421. PMID 15849355.
57. Wang Z, Chen Y, Labinskyy N, Hsieh TC, Ungvari Z, Wu JM (July 2006). "Regulation of proliferation and gene expression in cultured human aortic smooth muscle cells by resveratrol and standardized grape extracts". Biochem. Biophys. Res. Commun. 346 (1): 367"76. doi:10.1016/j.bbrc.2006.05.156. PMID 16759640.
58. Poussier B, Cordova AC, Becquemin JP, Sumpio BE (December 2005). "Resveratrol inhibits vascular smooth muscle cell proliferation and induces apoptosis". J. Vasc. Surg. 42 (6): 1190"7. doi:10.1016/j.jvs.2005.08.014. PMID 16376213.
59. Kurin E, Atanasov AG, Donath O, Heiss EH, Dirsch VM, Nagy M. Synergy study of the inhibitory potential of red wine polyphenols on vascular smooth muscle cell proliferation. Planta Med. 2012 May;78(8):772-8. doi: 10.1055/s-0031-1298440.Epub 2012 Apr 12. PubMed PMID: 22499559. http://www.ncbi.nlm.nih.gov/pubmed/22499559
60. Duffy SJ, Vita JA (February 2003). "Effects of phenolics on vascular endothelial function". Curr. Opin. Lipidol. 14 (1): 21"7. doi:10.1097/01.mol.0000052857.26236.f2. PMID 12544657.
61. Wallerath T, Deckert G, Ternes T, Anderson H, Li H, Witte K, Frstermann U (September 2002). "Resveratrol, a polyphenolic phytoalexin present in red wine, enhances expression and activity of endothelial nitric oxide synthase". Circulation 106 (13): 1652"8. doi:10.1161/01.CIR.0000029925.18593.5C. PMID 12270858.
62. Chen CK, Pace-Asciak CR (March 1996). "Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta". Gen. Pharmacol. 27 (2): 363"6. doi:10.1016/0306-3623(95)02001-2. PMID 8919657.
63. Olas B, Wachowicz B (August 2005). "Resveratrol, a phenolic antioxidant with effects on blood platelet functions". Platelets 16 (5): 251"60. doi:10.1080/09537100400020591. PMID 16011975.
64. Stef G, Csiszar A, Lerea K, Ungvari Z, Veress G (August 2006). "Resveratrol inhibits aggregation of platelets from high-risk cardiac patients with aspirin resistance". J. Cardiovasc. Pharmacol. 48 (2): 1"5. doi:10.1097/01.fjc.0000238592.67191.ab. PMID 16954814.
65. Wang Z, Zou J, Huang Y, Cao K, Xu Y, Wu JM (March 2002). "Effect of resveratrol on platelet aggregation in vivo and in vitro". Chin. Med. J. 115 (3): 378"80. PMID 11940369.
66. The red wine phenolicstrans-resveratrol and quercetin block human platelet aggregation and eicosanoid synthesis: Implications for protection against coronary heart disease. Cecil R. Pace-Asciak, Susan Hahn, Eleftherios P. Diamandis, George Soleas and David M. Goldberg, Clinica Chimica Acta, 31 March 1995, Volume 235, Issue 2, Pages 207"219, doi:10.1016/0009-8981(95)06045-1
67. Frmont L, Belguendouz L, Delpal S (1999). "Antioxidant activity of resveratrol and alcohol-free wine polyphenols related to LDL oxidation and polyunsaturated fatty acids". Life Sci. 64 (26): 2511"21. doi:10.1016/S0024-3205(99)00209-X. PMID 10403511.
68. Ungvari Z, Orosz Z, Rivera A, Labinskyy N, Xiangmin Z, Olson S, Podlutsky A, Csiszar A (May 2007). "Resveratrol increases vascular oxidative stress resistance". Am. J. Physiol. Heart Circ. Physiol. 292 (5): H2417"24. doi:10.1152/ajpheart.01258.2006. PMID 17220179.
69. Das DK, Maulik N (February 2006). "Resveratrol in cardioprotection: a therapeutic promise of alternative medicine". Mol. Interv. 6 (1): 36"47. doi:10.1124/mi.6.1.7. PMID 16507749.
70. Investigation Finds UConn Professor Fabricated Research - Work Focused On Resveratrol, Chemical In Red Wine Hartford Courant, January 11, 2012
71. Retraction Watch
72. Lamont KT, Somers S, Lacerda L, Opie LH, Lecour S (May 2011). "Is red wine a SAFE sip away from cardioprotection? Mechanisms involved in resveratrol- and melatonin-induced cardioprotection". J. Pineal Res. 50 (4): 374"80. doi:10.1111/j.1600-079X.2010.00853.x. PMID 21342247.
73. Su HC, Hung LM, Chen JK (June 2006). "Resveratrol, a red wine antioxidant, possesses an insulin-like effect in streptozotocin-induced diabetic rats". Am. J. Physiol. Endocrinol. Metab. 290 (6): E1339"46. doi:10.1152/ajpendo.00487.2005. PMID 16434553.
74. Deng JY, Hsieh PS, Huang JP, Lu LS, Hung LM (July 2008). "Activation of estrogen receptor is crucial for resveratrol-stimulating muscular glucose uptake via both insulin-dependent and -independent pathways". Diabetes 57 (7): 1814"23. doi:10.2337/db07-1750. PMC 2453636. PMID 18426865.
75. Palsamy P, Subramanian S (November 2008). "Resveratrol, a natural phytoalexin, normalizes hyperglycemia in streptozotocin-nicotinamide induced experimental diabetic rats". Biomed. Pharmacother. 62 (9): 598"605. doi:10.1016/j.biopha.2008.06.037. PMID 18675532.
76. Sharma S, Anjaneyulu M, Kulkarni SK, Chopra K (2006). "Resveratrol, a polyphenolic phytoalexin, attenuates diabetic nephropathy in rats". Pharmacology 76 (2): 69"75. doi:10.1159/000089720. PMID 16286809.
77. Schmatz R, Mazzanti CM, Spanevello R, Stefanello N, Gutierres J, Corra M, da Rosa MM, Rubin MA, Chitolina Schetinger MR, Morsch VM (May 2009). "Resveratrol prevents memory deficits and the increase in acetylcholinesterase activity in streptozotocin-induced diabetic rats". Eur. J. Pharmacol. 610 (1"3): 42"8. doi:10.1016/j.ejphar.2009.03.032. PMID 19303406.
78. Penumathsa SV, Thirunavukkarasu M, Zhan L, Maulik G, Menon VP, Bagchi D, Maulik N (December 2008). "Resveratrol enhances GLUT-4 translocation to the caveolar lipid raft fractions through AMPK/Akt/eNOS signalling pathway in diabetic myocardium". J. Cell. Mol. Med. 12 (6A): 2350"61. doi:10.1111/j.1582-4934.2008.00251.x. PMID 18266981.
79. "Sirtris Announces SRT501 Lowers Glucose in Twice-Daily Dosing Clinical Trial; Study Suggests Dose Response for Proprietary Formulation of Resveratrol in Type 2 Diabetics" (Press release). Sirtris Pharmaceuticals. April 17, 2008. Retrieved August 9, 2010.
80. "Sirtris Continues to Lead The Way In Resveratrol Based Research". My Resveratrol Experience. 2009-04-10. Retrieved 2011-01-22.
81. a b Marambaud P, Zhao H, Davies P (November 2005). "Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides". J. Biol. Chem. 280 (45): 37377"82. doi:10.1074/jbc.M508246200. PMID 16162502.
82. Karuppagounder SS, Pinto JT, Xu H, Chen HL, Beal MF, Gibson GE (February 2009). "Dietary supplementation with resveratrol reduces plaque pathology in a transgenic model of Alzheimer's disease". Neurochem. Int. 54 (2): 111"8. doi:10.1016/j.neuint.2008.10.008. PMC 2892907. PMID 19041676.
83. Vingtdeux V, Giliberto L, Zhao H, Chandakkar P, Wu Q, Simon JE, Janle EM, Lobo J, Ferruzzi MG, Davies P, Marambaud P (March 2010). "AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism". J. Biol. Chem. 285 (12): 9100"1. doi:10.1074/jbc.M109.060061. PMID 20080969.
84. Anekonda TS (September 2006). "Resveratrol--a boon for treating Alzheimer's disease?". Brain Res Rev 52 (2): 316"26. doi:10.1016/j.brainresrev.2006.04.004. PMID 16766037.
85. Sharma M, Gupta YK (October 2002). "Chronic treatment with trans resveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats". Life Sci. 71 (21): 2489"98. doi:10.1016/S0024-3205(02)02083-0. PMID 12270754.
86. Kumar P, Padi SS, Naidu PS, Kumar A (September 2006). "Effect of resveratrol on 3-nitropropionic acid-induced biochemical and behavioural changes: possible neuroprotective mechanisms". Behav Pharmacol 17 (5"6): 485"92. doi:10.1097/00008877-200609000-00014. PMID 16940769.
87. Yang YB, Piao YJ (July 2003). "Effects of resveratrol on secondary damages after acute spinal cord injury in rats". Acta Pharmacol. Sin. 24 (7): 703"10. PMID 12852839.
88. Sinha K, Chaudhary G, Gupta YK (June 2002). "Protective effect of resveratrol against oxidative stress in middle cerebral artery occlusion model of stroke in rats". Life Sci. 71 (6): 655"65. doi:10.1016/S0024-3205(02)01691-0. PMID 12072154.
89. Gentilli M, Mazoit JX, Bouaziz H, Fletcher D, Casper RF, Benhamou D, Savouret JF (February 2001). "Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw". Life Sci. 68 (11): 1317"21. doi:10.1016/S0024-3205(00)01018-3. PMID 11233998.
90. Tsai SH, Lin-Shiau SY, Lin JK (February 1999). "Suppression of nitric oxide synthase and the down-regulation of the activation of NFkappaB in macrophages by resveratrol". Br. J. Pharmacol. 126 (3): 673"80. doi:10.1038/sj.bjp.0702357. PMC 1565862. PMID 10188978.
91. Elmali N, Baysal O, Harma A, Esenkaya I, Mizrak B (April 2007). "Effects of resveratrol in inflammatory arthritis". Inflammation 30 (1"2): 1"6. doi:10.1007/s10753-006-9012-0. PMID 17115116.
92.Docherty JJ, Fu MM, Stiffler BS, Limperos RJ, Pokabla CM, DeLucia AL (October 1999). "Resveratrol inhibition of herpes simplex virus replication". Antiviral Res. 43 (3): 145"55. doi:10.1016/S0166-3542(99)00042-X. PMID 10551373.
93. Docherty JJ, Fu MM, Hah JM, Sweet TJ, Faith SA, Booth T (September 2005). "Effect of resveratrol on herpes simplex virus vaginal infection in the mouse". Antiviral Res. 67 (3): 155"62. doi:10.1016/j.antiviral.2005.06.008. PMID 16125258.
94. Docherty JJ, Smith JS, Fu MM, Stoner T, Booth T (January 2004). "Effect of topically applied resveratrol on cutaneous herpes simplex virus infections in hairless mice". Antiviral Res. 61 (1): 19"26. doi:10.1016/j.antiviral.2003.07.001. PMID 14670590.
95. Docherty JJ, Sweet TJ, Bailey E, Faith SA, Booth T (December 2006). "Resveratrol inhibition of varicella-zoster virus replication in vitro". Antiviral Res. 72 (3): 171"7. doi:10.1016/j.antiviral.2006.07.004. PMID 16899306.
96. Guan WD, Yang ZF, Liu N, Qin S, Zhang FX, Zhu YT (September 2008). "[In vitro experimental study on the effect of resveratrol against several kinds of respiroviruses]". Zhong Yao Cai (in Chinese) 31 (9): 1388"90. PMID 19180966.
97. Palamara AT, Nencioni L, Aquilano K, De Chiara G, Hernandez L, Cozzolino F, Ciriolo MR, Garaci E (May 2005). "Inhibition of influenza A virus replication by resveratrol". J. Infect. Dis. 191 (10): 1719"29. doi:10.1086/429694. PMID 15838800.
98. Li YQ, Li ZL, Zhao WJ, Wen RX, Meng QW, Zeng Y (September 2006). "Synthesis of stilbene derivatives with inhibition of SARS coronavirus replication". Eur J Med Chem 41 (9): 1084"9. doi:10.1016/j.ejmech.2006.03.024. PMID 16875760.
99. Evers DL, Wang X, Huong SM, Huang DY, Huang ES (August 2004). "3,4',5-Trihydroxy-trans-stilbene (resveratrol) inhibits human cytomegalovirus replication and virus-induced cellular signaling". Antiviral Res. 63 (2): 85"95. doi:10.1016/j.antiviral.2004.03.002. PMID 15302137.
Excerpt from:
Resveratrol Extract Powder - Z Natural Foods
Recommendation and review posted by G. Smith
